Literature DB >> 23006218

Long-term clinical outcomes and survivorship after total knee arthroplasty using a rotating platform knee prosthesis: a meta-analysis.

Colin D J Hopley1, Lawrence S Crossett, Antonia F Chen.   

Abstract

A systematic search identified 29 papers reporting survivorship and clinical and function Knee Society Scores (KSS) of 6437 total knee replacements using the Low Contact Stress (LCS) Rotating Platform (RP) mobile bearing knee. Low Contact Stress RP survivorship and KSS outcomes were compared with non-LCS knees in the Swedish knee registry at comparable time periods and in 2 independent systematic reviews of knee arthroplasty outcomes. There is a substantial body of mainly observational evidence supporting the LCS RP knee. Knee Society Score outcomes were comparable for LCS RP and non-LCS RP knees at up to 15 years of follow-up, with mean clinical and function scores ranging from 72 to 96 and 58 to 90, respectively. Survivorship of LCS RP knees up to 14 years was higher than that for all knees in the Swedish Knee Registry.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23006218     DOI: 10.1016/j.arth.2012.04.026

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  22 in total

1.  Mobility of the rotating platform in low contact stress knee arthroplasty is durable.

Authors:  Arthur Zürcher; Kim van Hutten; Jaap Harlaar; Ruud Pöll
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2015-10-16       Impact factor: 4.342

2.  Effect of age on cost-effectiveness of unicompartmental knee arthroplasty compared with total knee arthroplasty in the U.S.

Authors:  Hassan M Ghomrawi; Ashley A Eggman; Andrew D Pearle
Journal:  J Bone Joint Surg Am       Date:  2015-03-04       Impact factor: 5.284

3.  No difference in joint awareness after mobile- and fixed-bearing total knee arthroplasty: 3-year follow-up of a randomized controlled trial.

Authors:  M G M Schotanus; P Pilot; R Vos; N P Kort
Journal:  Eur J Orthop Surg Traumatol       Date:  2017-02-09

Review 4.  Rotating-platform TKA no different from fixed-bearing TKA regarding survivorship or performance: a meta-analysis.

Authors:  Joseph T Moskal; Susan G Capps
Journal:  Clin Orthop Relat Res       Date:  2014-03-04       Impact factor: 4.176

5.  CORR Insights®: Rotating-platform TKA no different from fixed-bearing TKA regarding survivorship or performance: a meta-analysis.

Authors:  Tae Kyun Kim
Journal:  Clin Orthop Relat Res       Date:  2014-03-26       Impact factor: 4.176

6.  The effect of different insert design congruencies on the kinematics of a mobile bearing TKA: A cadaveric study.

Authors:  Gianluca Castellarin; Edoardo Bori; Alessandra Menon; Bernardo Innocenti
Journal:  J Orthop       Date:  2022-08-10

7.  No difference in terms of radiostereometric analysis between fixed- and mobile-bearing total knee arthroplasty: a randomized, single-blind, controlled trial.

Authors:  M G M Schotanus; P Pilot; B L Kaptein; W F Draijer; P B J Tilman; R Vos; N P Kort
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2016-04-27       Impact factor: 4.342

8.  Minimum twelve-year follow-up of fixed- vs mobile-bearing total knee arthroplasty: Double blinded randomized trial.

Authors:  Cameron J Killen; Michael P Murphy; William J Hopkinson; Melvyn A Harrington; William H Adams; Harold W Rees
Journal:  J Clin Orthop Trauma       Date:  2019-03-29

9.  Experimental and clinical analysis of the use of asymmetric vs symmetric polyethylene inserts in a mobile bearing total knee arthroplasty.

Authors:  Gianluca Castellarin; Edoardo Bori; Bernardo Innocenti
Journal:  J Orthop       Date:  2020-12-29

10.  Design and rationale of the ATtune Knee Outcome Study (ATKOS): multicenter prospective evaluation of a novel uncemented rotating platform knee system.

Authors:  Rachid Rassir; Inger N Sierevelt; Marjolein Schager; Peter A Nolte
Journal:  BMC Musculoskelet Disord       Date:  2021-07-15       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.